Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer ; volume:8 ; number:1 ; day:29 ; month:5 ; year:2008 ; pages:1-10 ; date:12.2008
BMC cancer ; 8, Heft 1 (29.5.2008), 1-10, 12.2008
- Urheber
-
Callagy, Grace M.
- Beteiligte Personen und Organisationen
-
Webber, Mark J.
Pharoah, Paul DP
Caldas, Carlos
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-8-153
- URN
-
urn:nbn:de:1111-2016030349648
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Callagy, Grace M.
- Webber, Mark J.
- Pharoah, Paul DP
- Caldas, Carlos
- SpringerLink (Online service)
Ähnliche Objekte (12)
MFNG is an independent prognostic marker for osteosarcoma
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2
RECK is not an independent prognostic marker for breast cancer
EP3 is an independent prognostic marker only for unifocal breast cancer cases
Comparative analysis of complete mitochondrial genome sequences confirms independent origins of plant-parasitic nematodes
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients
A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
MFNG is an independent prognostic marker for osteosarcoma
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2
RECK is not an independent prognostic marker for breast cancer
EP3 is an independent prognostic marker only for unifocal breast cancer cases
Comparative analysis of complete mitochondrial genome sequences confirms independent origins of plant-parasitic nematodes
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients
A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
MFNG is an independent prognostic marker for osteosarcoma
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2
RECK is not an independent prognostic marker for breast cancer
EP3 is an independent prognostic marker only for unifocal breast cancer cases
Comparative analysis of complete mitochondrial genome sequences confirms independent origins of plant-parasitic nematodes
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients
A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer